Human Molecular Genetics Advance Access originally published online on June 15, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2004, Vol. 13, No. 16 1745-1754
DOI: 10.1093/hmg/ddh180
Human Molecular Genetics, Vol. 13, No. 16 © Oxford University Press 2004; all rights reserved
Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis
Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, NY 14214, USA
Received April 8, 2004; Accepted June 1, 2004
Parkinson's disease (PD) is characterized by the selective degeneration of dopaminergic (DA) neurons in substantia nigra pars compacta (SNpc). A combination of genetic and environmental factors contributes to such a specific loss. Among the five PD-linked genes identified so far, parkin, a protein-ubiquitin E3 ligase, appears to be the most prevalent genetic factor in PD. Although a variety of substrates have been identified for parkin, none of them is selectively expressed in nigral DA neurons. It remains unclear how accumulation of these substrates in the absence of functional parkin may cause the selective death of DA neurons in SNpc. Here, we show that overexpression of parkin protected human DA neuroblastoma cell line (SH-SY5Y) against apoptosis induced by DA or 6-OHDA, but not by H2O2 or rotenone. Parkin significantly attenuated dopamine-induced activation of c-Jun N-terminal kinase (JNK) and caspase-3. It also decreased the level of reactive oxygen species (ROS) and protein carbonyls in the cell. Inhibiting DA uptake through dopamine transporter or treating the cell with antioxidants significantly reduced oxidative stress and dopamine toxicity. Furthermore, PD-linked mutations of parkin significantly abrogated the protective effect of wild-type parkin, as well as its ability to suppress ROS and protein carbonylation. These results suggest that parkin protects against dopamine toxicity by decreasing oxidative stress and ensuing activation of apoptotic programs such as the JNK/caspase pathway. This protective function of parkin, which is greatly attenuated by its PD-linked mutations, may be uniquely important for the survival of DA neurons, as they are constantly threatened by oxyradicals produced during dopamine oxidation.
* To whom correspondence should be addressed at: Department of Physiology and Biophysics, State University of New York at Buffalo, 124 Sherman Hall, Buffalo, NY 14214, USA. Tel: +1 7168292345; Fax: +1 7168292699; Email: jianfeng{at}buffalo.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Nakajima, W. Amano, T. Kubo, A. Fukuhara, H. Ihara, Y.-T. Azuma, H. Tajima, T. Inui, A. Sawa, and T. Takeuchi Glyceraldehyde-3-phosphate Dehydrogenase Aggregate Formation Participates in Oxidative Stress-induced Cell Death J. Biol. Chem., December 4, 2009; 284(49): 34331 - 34341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Rothfuss, H. Fischer, T. Hasegawa, M. Maisel, P. Leitner, F. Miesel, M. Sharma, A. Bornemann, D. Berg, T. Gasser, et al. Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair Hum. Mol. Genet., October 15, 2009; 18(20): 3832 - 3850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Shenoy, Y. Wu, and S. Pervaiz LY303511 Enhances TRAIL Sensitivity of SHEP-1 Neuroblastoma Cells via Hydrogen Peroxide-Mediated Mitogen-Activated Protein Kinase Activation and Up-regulation of Death Receptors Cancer Res., March 1, 2009; 69(5): 1941 - 1950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ren, H. Jiang, F. Yang, K. Nakaso, and J. Feng Parkin Protects Dopaminergic Neurons against Microtubule-depolymerizing Toxins by Attenuating Microtubule-associated Protein Kinase Activation J. Biol. Chem., February 6, 2009; 284(6): 4009 - 4017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kawahara, M. Hashimoto, P. Bar-On, G. J. Ho, L. Crews, H. Mizuno, E. Rockenstein, S. Z. Imam, and E. Masliah {alpha}-Synuclein Aggregates Interfere with Parkin Solubility and Distribution: ROLE IN THE PATHOGENESIS OF PARKINSON DISEASE J. Biol. Chem., March 14, 2008; 283(11): 6979 - 6987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Weihofen, B. Ostaszewski, Y. Minami, and D. J. Selkoe Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1 Hum. Mol. Genet., February 14, 2008; 17(4): 602 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pan, G. Wang, H.-Q. Yang, Z. Hong, Q. Xiao, R.-J. Ren, H.-Y. Zhou, L. Bai, and S.-D. Chen K252a Prevents Nigral Dopaminergic Cell Death Induced by 6-Hydroxydopamine through Inhibition of Both Mixed-Lineage Kinase 3/c-Jun NH2-Terminal Kinase 3 (JNK3) and Apoptosis-Inducing Kinase 1/JNK3 Signaling Pathways Mol. Pharmacol., December 1, 2007; 72(6): 1607 - 1618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. H. Henn, L. Bouman, J. S. Schlehe, A. Schlierf, J. E. Schramm, E. Wegener, K. Nakaso, C. Culmsee, B. Berninger, D. Krappmann, et al. Parkin Mediates Neuroprotection through Activation of I{kappa}B Kinase/Nuclear Factor-{kappa}B Signaling J. Neurosci., February 21, 2007; 27(8): 1868 - 1878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jiang, Q. Jiang, W. Liu, and J. Feng Parkin Suppresses the Expression of Monoamine Oxidases J. Biol. Chem., March 31, 2006; 281(13): 8591 - 8599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wang, H. S. Ko, B. Thomas, F. Tsang, K. C.M. Chew, S.-P. Tay, M. W.L. Ho, T.-M. Lim, T.-W. Soong, O. Pletnikova, et al. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function Hum. Mol. Genet., December 15, 2005; 14(24): 3885 - 3897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ren, W. Liu, H. Jiang, Q. Jiang, and J. Feng Selective Vulnerability of Dopaminergic Neurons to Microtubule Depolymerization J. Biol. Chem., October 7, 2005; 280(40): 34105 - 34112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-H. Cha, S. Kim, J. Park, E. Lee, M. Kim, S. B. Lee, J. M. Kim, J. Chung, and K. S. Cho Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila PNAS, July 19, 2005; 102(29): 10345 - 10350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Whitworth, D. A. Theodore, J. C. Greene, H. Benes, P. D. Wes, and L. J. Pallanck Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease PNAS, May 31, 2005; 102(22): 8024 - 8029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yamamoto, A. Friedlein, Y. Imai, R. Takahashi, P. J. Kahle, and C. Haass Parkin Phosphorylation and Modulation of Its E3 Ubiquitin Ligase Activity J. Biol. Chem., February 4, 2005; 280(5): 3390 - 3399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jiang, Q. Jiang, and J. Feng Parkin Increases Dopamine Uptake by Enhancing the Cell Surface Expression of Dopamine Transporter J. Biol. Chem., December 24, 2004; 279(52): 54380 - 54386. [Abstract] [Full Text] [PDF]
|
|